1. Scrip
  2. >>Business

Sun Firefights Governance Concerns

 
• By Anju Ghangurde

Sun has promised to implement certain changes to address corporate governance concerns that have riled investors, including “unwinding” a loan transaction and doing away with a controversial related party arrangement for domestic sales. But will that be enough for markets to "forget" allegations of lapses or "re-rate" the firm any time soon?

Extinguisher
SUN HAS MOVED TO CONTROL DAMAGE AMID ALLEGATIONS OF GOVERNANCE LAPSES • Source: Shutterstock

India’s top-ranked drug firm, Sun Pharmaceutical Industries Ltd., swung into damage control mode amid ongoing concerns about serious corporate governance lapses, promising to fine-tune certain business transactions that have been a sticking point with investors.

Sun, which at an investor call last month indicated its intent to modify certain opaque business transactions should that soothe frayed investor nerves,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Atara Does An About Face As FDA Lifts Ebvallo Hold

 
• By Alaric DeArment

The biotech said it will have a type A meeting with the agency to resubmit for the cell therapy’s approval in EBV+ PTLD.

Lilly And Alchemab Tap Into Resilient Individuals To Develop ALS Drug

 
• By Andrew McConaghie

The pharma company is helping to validate the biotech’s model by developing a novel amyotrophic lateral sclerosis candidate, based on its novel approach that ‘turns drug discovery on its head’.

Switzerland Biopharma To Stay Strong Despite More Cash Going To US And China

 
• By Kevin Grogan

The sector is continuing to show resilience despite financial and market challenges.